• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无肝细胞癌的酒精性肝病患者血清去γ-羧基凝血酶原水平升高。

Increase of serum des-gamma-carboxy prothrombin in alcoholic liver disease without hepatocellular carcinoma.

作者信息

Ohhira M, Ohtake T, Saito H, Ikuta K, Tanaka K, Tanabe H, Kawashima T, Fujimoto Y, Naraki T, Ono M, Kohgo Y

机构信息

Third Department of Internal Medicine, Asahikawa Medical College, Hokkaido, Japan.

出版信息

Alcohol Clin Exp Res. 1999 Apr;23(4 Suppl):67S-70S. doi: 10.1111/j.1530-0277.1999.tb04537.x.

DOI:10.1111/j.1530-0277.1999.tb04537.x
PMID:10235282
Abstract

The purpose of this study is to determine serum des-gamma-carboxy prothrombin (DCP) levels in benign liver diseases by a new sensitive method, and to demonstrate the elevation of serum DCP in alcoholic liver disease (ALD) without hepatocellular carcinoma (HCC). Median values of serum DCP were 16.2 mAU/ml (range: 3.2 to 1570 mAU/ml) in ALD and 16.7 mAU/ml (1.2 to 75.4 mAU/ml) in viral liver disease (VLD). Using the cut-off value of 40 mAU/ml as a tumor marker for HCC, 21% (11/52) was positive in ALD and 2% (1/57) was positive in VLD (p = 0.0014, Fisher's exact probability test), and 27% (9/33) was positive in alcoholic liver cirrhosis and 3% (1/39) was positive in viral liver cirrhosis (p = 0.0042, Fisher's exact probability test). The positive rate of DCP was significantly (p < 0.001, Spearman's rank correlation test) correlated with the severity of liver disease in ALD. Serum vitamin K level was not decreased in cases with ALD. In a demonstrable case, serum DCP was decreased after abstinence and was increased again after the beginning of ethanol intake, suggesting the involvement of ethanol to the elevation of serum DCP in ALD. In conclusion, serum DCP was significantly elevated in ALD, compared with VLD, although the mechanism of the elevation of DCP was not clarified. Ethanol intake may act, in part, on the increase of serum DCP in ALD.

摘要

本研究旨在通过一种新的敏感方法测定良性肝病患者血清去γ-羧基凝血酶原(DCP)水平,并证实酒精性肝病(ALD)无肝细胞癌(HCC)时血清DCP升高。ALD患者血清DCP中位数为16.2 mAU/ml(范围:3.2至1570 mAU/ml),病毒性肝病(VLD)患者为16.7 mAU/ml(1.2至75.4 mAU/ml)。以40 mAU/ml作为HCC的肿瘤标志物临界值,ALD患者阳性率为21%(11/52),VLD患者为2%(1/57)(p = 0.0014,Fisher确切概率检验),酒精性肝硬化患者阳性率为27%(9/33),病毒性肝硬化患者为3%(1/39)(p = 0.0042,Fisher确切概率检验)。ALD患者中DCP阳性率与肝病严重程度显著相关(p < 0.001,Spearman等级相关检验)。ALD患者血清维生素K水平未降低。在一个可证实的病例中,戒酒血清DCP降低,重新摄入乙醇后又升高,提示乙醇参与ALD患者血清DCP升高。总之,与VLD相比,ALD患者血清DCP显著升高,尽管DCP升高机制尚不清楚。乙醇摄入可能部分作用于ALD患者血清DCP升高。

相似文献

1
Increase of serum des-gamma-carboxy prothrombin in alcoholic liver disease without hepatocellular carcinoma.无肝细胞癌的酒精性肝病患者血清去γ-羧基凝血酶原水平升高。
Alcohol Clin Exp Res. 1999 Apr;23(4 Suppl):67S-70S. doi: 10.1111/j.1530-0277.1999.tb04537.x.
2
A variant of des-gamma-carboxy prothrombin was increased in alcoholic liver disease without hepatocellular carcinoma.在无肝细胞癌的酒精性肝病中,去γ-羧基凝血酶原的一种变体增加。
Alcohol Clin Exp Res. 2001 Jun;25(6 Suppl):46S-50S. doi: 10.1097/00000374-200106001-00011.
3
Measurement of serum levels of des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity.采用灵敏度提高的改良酶免疫分析试剂盒测定肝细胞癌患者血清中去γ-羧基凝血酶原水平。
Cancer. 1999 Feb 15;85(4):812-8.
4
The usefulness of determining des-gamma-carboxy prothrombin by sensitive enzyme immunoassay in the early diagnosis of patients with hepatocellular carcinoma.采用灵敏酶免疫测定法检测去γ-羧基凝血酶原在肝细胞癌患者早期诊断中的应用价值。
Cancer. 1998 May 1;82(9):1643-8. doi: 10.1002/(sici)1097-0142(19980501)82:9<1643::aid-cncr8>3.0.co;2-b.
5
Plasma abnormal prothrombin (des-gamma-carboxy prothrombin) as a marker of hepatocellular carcinoma.血浆异常凝血酶原(去γ-羧基凝血酶原)作为肝细胞癌的标志物。
Cancer. 1988 Apr 15;61(8):1621-8. doi: 10.1002/1097-0142(19880415)61:8<1621::aid-cncr2820610820>3.0.co;2-c.
6
Abnormal prothrombin (DES-gamma-carboxy prothrombin) in hepatocellular carcinoma.肝细胞癌中的异常凝血酶原(脱γ-羧基凝血酶原)
Hepatogastroenterology. 1991 Oct;38(5):450-3.
7
The influence of alcoholic liver disease on serum PIVKA-II levels in patients without hepatocellular carcinoma.酒精性肝病对无肝细胞癌患者血清异常凝血酶原水平的影响。
Gut Liver. 2015 Mar;9(2):224-30. doi: 10.5009/gnl14047.
8
The serum level of NX-DCP-R, but not DCP, is not increased in alcoholic liver disease without hepatocellular carcinoma.血清 NX-DCP-R 水平,而非 DCP,在非肝细胞肝癌的酒精性肝病中没有升高。
Cancer Biomark. 2016;16(1):171-80. doi: 10.3233/CBM-150553.
9
Diagnostic utility of alpha-fetoprotein and des-gamma-carboxyprothrombin in nigerians with hepatocellular carcinoma.甲胎蛋白和异常凝血酶原在尼日利亚肝细胞癌患者中的诊断效用
Niger J Clin Pract. 2017 Oct;20(10):1267-1272. doi: 10.4103/njcp.njcp_398_16.
10
Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.采用高敏电化学发光系统检测血清去γ-羧基凝血酶原水平的序贯波动模式,作为肝硬化患者肝细胞癌的早期预测标志物。
Int J Mol Med. 2002 Mar;9(3):245-50.

引用本文的文献

1
Better performance of PIVKA-II for detecting hepatocellular carcinoma in patients with chronic liver disease with normal total bilirubin.对于总胆红素正常的慢性肝病患者,异常凝血酶原(PIVKA-II)在检测肝细胞癌方面的表现更好。
World J Gastroenterol. 2023 Feb 28;29(8):1359-1373. doi: 10.3748/wjg.v29.i8.1359.
2
Diagnostic Role of Tumor Markers for Hepatocellular Carcinoma in Liver Transplantation Candidates: An Analysis Using the Korean Organ Transplantation Registry Database.肿瘤标志物对肝移植候选者肝细胞癌的诊断作用:利用韩国器官移植登记数据库进行的分析。
Ann Transplant. 2022 Sep 13;27:e936937. doi: 10.12659/AOT.936937.
3
Validation of the GALAD Model and Establishment of GAAP Model for Diagnosis of Hepatocellular Carcinoma in Chinese Patients.
GALAD模型的验证及GAAP模型的建立用于中国患者肝细胞癌的诊断
J Hepatocell Carcinoma. 2020 Oct 23;7:219-232. doi: 10.2147/JHC.S271790. eCollection 2020.
4
Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey.日本非酒精性脂肪性肝病和酒精性肝病患者的肝细胞癌:多中心调查。
J Gastroenterol. 2016 Jun;51(6):586-96. doi: 10.1007/s00535-015-1129-1. Epub 2015 Oct 11.
5
Imaging of focal nodular hyperplastic-like nodules in alcoholic liver cirrhosis patients using gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid magnetic resonance imaging.使用钆乙氧基苄基二乙三胺五乙酸磁共振成像对酒精性肝硬化患者的局灶性结节样增生样结节进行成像。
Clin J Gastroenterol. 2011 Aug;4(4):266-272. doi: 10.1007/s12328-011-0244-7. Epub 2011 Jul 14.
6
The influence of alcoholic liver disease on serum PIVKA-II levels in patients without hepatocellular carcinoma.酒精性肝病对无肝细胞癌患者血清异常凝血酶原水平的影响。
Gut Liver. 2015 Mar;9(2):224-30. doi: 10.5009/gnl14047.
7
Des-γ-carboxy prothrombin ratio measured by P-11 and P-16 antibodies is a novel biomarker for hepatocellular carcinoma.由 P-11 和 P-16 抗体测定的去γ-羧基凝血酶原比率是肝细胞癌的一种新型生物标志物。
Cancer Sci. 2013 Jun;104(6):725-31. doi: 10.1111/cas.12149. Epub 2013 Apr 21.
8
Biochemical markers for alcohol consumption.酒精摄入的生化标志物。
Indian J Clin Biochem. 2003 Jul;18(2):111-8. doi: 10.1007/BF02867376.
9
O Labeling for a Quantitative Proteomic Analysis of Glycoproteins in Hepatocellular Carcinoma.肝细胞癌中糖蛋白定量蛋白质组分析的标签
Clin Proteomics. 2008 Jul 18;4(3-4):137-155. doi: 10.1007/s12014-008-9013-0.
10
Intestinal absorption of mixed micellar phylloquinone (vitamin K1) is unreliable in infants with conjugated hyperbilirubinaemia: implications for oral prophylaxis of vitamin K deficiency bleeding.对于患有结合型高胆红素血症的婴儿,混合微胶粒叶绿醌(维生素K1)的肠道吸收不可靠:对维生素K缺乏性出血症口服预防的意义。
Arch Dis Child Fetal Neonatal Ed. 2003 Mar;88(2):F113-8. doi: 10.1136/fn.88.2.f113.